Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge

Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We ha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of allergy, asthma, & immunology asthma, & immunology, 2021-08, Vol.127 (2), p.249-256.e2
Hauptverfasser: Palikhe, Nami Shrestha, Gandhi, Vivek Dipak, Wu, Yingqi, Sinnatamby, Tristan, Rowe, Brian H., Mayers, Irvin, Cameron, Lisa, Vliagoftis, Harissios
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 256.e2
container_issue 2
container_start_page 249
container_title Annals of allergy, asthma, & immunology
container_volume 127
creator Palikhe, Nami Shrestha
Gandhi, Vivek Dipak
Wu, Yingqi
Sinnatamby, Tristan
Rowe, Brian H.
Mayers, Irvin
Cameron, Lisa
Vliagoftis, Harissios
description Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes. To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge. A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients. PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment. Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.
doi_str_mv 10.1016/j.anai.2021.04.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2518741288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1081120621002982</els_id><sourcerecordid>2518741288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</originalsourceid><addsrcrecordid>eNp9kc1O3DAUhSNUJCj0BVh52U1S_yVxpG4Qoj8SEizatXVj38x4lNip7UHlYfquOB3WrHx0_B1b956qumG0YZR1Xw4NeHANp5w1VDbFOqsuWStkLaXoPhRNFasZp91F9TGlA6WUqU5cVv-eMLp1jxFmMs4hWOJ8xrigdZCRLMEH81LEGkNGSFiDye65XFkS0eCaQ6w5wb9rxJRc8CVu4gYmYo_R-R2BlPcLFAQMxhFygRIBbwlM5aPC72H-7xKYZ4w79MTsN-l3eF2dTzAn_PR2XlW_v93_uvtRPzx-_3l3-1AbIUSuBzvQQXAzdZuaOPSi52hB8a5FaqwQk2zHEToGSrSKDWoQ0Pdg2laOtJfiqvp8ereM-eeIKevFJYPzDB7DMWneMtVLxpUqKD-hJoaUIk56jW6B-KIZ1VsX-qC3LvTWhaZSF6uEvp5CWIZ4dhh1Mg69KVsuW8zaBvde_BU1Epbz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2518741288</pqid></control><display><type>article</type><title>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Palikhe, Nami Shrestha ; Gandhi, Vivek Dipak ; Wu, Yingqi ; Sinnatamby, Tristan ; Rowe, Brian H. ; Mayers, Irvin ; Cameron, Lisa ; Vliagoftis, Harissios</creator><creatorcontrib>Palikhe, Nami Shrestha ; Gandhi, Vivek Dipak ; Wu, Yingqi ; Sinnatamby, Tristan ; Rowe, Brian H. ; Mayers, Irvin ; Cameron, Lisa ; Vliagoftis, Harissios</creatorcontrib><description>Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes. To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge. A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients. PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment. Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.</description><identifier>ISSN: 1081-1206</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/j.anai.2021.04.016</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Annals of allergy, asthma, &amp; immunology, 2021-08, Vol.127 (2), p.249-256.e2</ispartof><rights>2021 American College of Allergy, Asthma &amp; Immunology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</citedby><cites>FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anai.2021.04.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids></links><search><creatorcontrib>Palikhe, Nami Shrestha</creatorcontrib><creatorcontrib>Gandhi, Vivek Dipak</creatorcontrib><creatorcontrib>Wu, Yingqi</creatorcontrib><creatorcontrib>Sinnatamby, Tristan</creatorcontrib><creatorcontrib>Rowe, Brian H.</creatorcontrib><creatorcontrib>Mayers, Irvin</creatorcontrib><creatorcontrib>Cameron, Lisa</creatorcontrib><creatorcontrib>Vliagoftis, Harissios</creatorcontrib><title>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</title><title>Annals of allergy, asthma, &amp; immunology</title><description>Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes. To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge. A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients. PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment. Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.</description><issn>1081-1206</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3DAUhSNUJCj0BVh52U1S_yVxpG4Qoj8SEizatXVj38x4lNip7UHlYfquOB3WrHx0_B1b956qumG0YZR1Xw4NeHANp5w1VDbFOqsuWStkLaXoPhRNFasZp91F9TGlA6WUqU5cVv-eMLp1jxFmMs4hWOJ8xrigdZCRLMEH81LEGkNGSFiDye65XFkS0eCaQ6w5wb9rxJRc8CVu4gYmYo_R-R2BlPcLFAQMxhFygRIBbwlM5aPC72H-7xKYZ4w79MTsN-l3eF2dTzAn_PR2XlW_v93_uvtRPzx-_3l3-1AbIUSuBzvQQXAzdZuaOPSi52hB8a5FaqwQk2zHEToGSrSKDWoQ0Pdg2laOtJfiqvp8ereM-eeIKevFJYPzDB7DMWneMtVLxpUqKD-hJoaUIk56jW6B-KIZ1VsX-qC3LvTWhaZSF6uEvp5CWIZ4dhh1Mg69KVsuW8zaBvde_BU1Epbz</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Palikhe, Nami Shrestha</creator><creator>Gandhi, Vivek Dipak</creator><creator>Wu, Yingqi</creator><creator>Sinnatamby, Tristan</creator><creator>Rowe, Brian H.</creator><creator>Mayers, Irvin</creator><creator>Cameron, Lisa</creator><creator>Vliagoftis, Harissios</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202108</creationdate><title>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</title><author>Palikhe, Nami Shrestha ; Gandhi, Vivek Dipak ; Wu, Yingqi ; Sinnatamby, Tristan ; Rowe, Brian H. ; Mayers, Irvin ; Cameron, Lisa ; Vliagoftis, Harissios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-9d90932cf69d90f2a7372eda8265e0cd33f45bba61a835819893a77ac554b0743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palikhe, Nami Shrestha</creatorcontrib><creatorcontrib>Gandhi, Vivek Dipak</creatorcontrib><creatorcontrib>Wu, Yingqi</creatorcontrib><creatorcontrib>Sinnatamby, Tristan</creatorcontrib><creatorcontrib>Rowe, Brian H.</creatorcontrib><creatorcontrib>Mayers, Irvin</creatorcontrib><creatorcontrib>Cameron, Lisa</creatorcontrib><creatorcontrib>Vliagoftis, Harissios</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palikhe, Nami Shrestha</au><au>Gandhi, Vivek Dipak</au><au>Wu, Yingqi</au><au>Sinnatamby, Tristan</au><au>Rowe, Brian H.</au><au>Mayers, Irvin</au><au>Cameron, Lisa</au><au>Vliagoftis, Harissios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge</atitle><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle><date>2021-08</date><risdate>2021</risdate><volume>127</volume><issue>2</issue><spage>249</spage><epage>256.e2</epage><pages>249-256.e2</pages><issn>1081-1206</issn><eissn>1534-4436</eissn><abstract>Myeloid cells, especially dendritic cells and macrophages, play important roles in asthma pathophysiology. Monocytes (Mo) and macrophages express protease-activated receptor-2 (PAR-2), a proinflammatory serine protease receptor implicated in the pathophysiology of allergic airway inflammation. We have revealed that patients with severe asthma and those with a history of frequent asthma exacerbations exhibit increased PAR-2 expression on peripheral blood monocytes. To determine PAR-2 expression on peripheral blood intermediate monocytes (IMMo) in subjects with increased airway inflammation, either as a result of an asthma exacerbation or after an inhalation allergen challenge. A total of 16 adults who presented to the emergency department with asthma exacerbations were recruited after giving an informed consent. After 2 weeks, 10 patients returned for follow-up. A total of 11 patients with mild asthma treated only with as-needed bronchodilators were recruited and underwent inhalation allergen challenge after providing an informed consent. Immune cell profiling was performed by whole blood flow cytometry in both groups of patients. PAR-2 expression in peripheral blood IMMo increased in patients with an asthma exacerbation compared with those with stable disease, but this expression decreased after treatment of the asthma exacerbation. Subjects with mild asthma had an increase in percentages of IMMo expressing PAR-2 after an allergen challenge. Patients who presented to the emergency department had lower dendritic cell and dendritic cell subset numbers in peripheral blood during exacerbation compared with after treatment. Increased PAR-2 expression on Mo during periods of increased airway inflammation may initiate a positive feedback loop leading to systemic inflammatory changes.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.anai.2021.04.016</doi></addata></record>
fulltext fulltext
identifier ISSN: 1081-1206
ispartof Annals of allergy, asthma, & immunology, 2021-08, Vol.127 (2), p.249-256.e2
issn 1081-1206
1534-4436
language eng
recordid cdi_proquest_miscellaneous_2518741288
source ScienceDirect Journals (5 years ago - present)
title Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A55%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20blood%20intermediate%20monocyte%20protease-activated%20receptor-2%20expression%20increases%20during%20asthma%20exacerbations%20and%20after%20inhalation%20allergen%20challenge&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Palikhe,%20Nami%20Shrestha&rft.date=2021-08&rft.volume=127&rft.issue=2&rft.spage=249&rft.epage=256.e2&rft.pages=249-256.e2&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/j.anai.2021.04.016&rft_dat=%3Cproquest_cross%3E2518741288%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2518741288&rft_id=info:pmid/&rft_els_id=S1081120621002982&rfr_iscdi=true